32 results on '"Awasthy, Disha"'
Search Results
2. Optimization of Compound Plate Preparation to Address Precipitation Issue in Mammalian A549 Cytotoxicity Assay
3. Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure–activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose 2′-oxidase
4. Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target
5. W48. PROFILING THE RARE VARIANT GENETIC RISK FOR DEMENTIA WITH WHOLE EXOME SEQUENCING: A STUDY FROM INDIA
6. Essentiality and functional analysis of type I and type III pancolienate kinases of Mycobacterium tuberculosis
7. Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice
8. Whole cell screen based identification of spiropiperidines with potent antitubercular properties
9. Optimization of Compound Plate Preparation to Address Precipitation Issue in Mammalian A549 Cytotoxicity Assay
10. Clinical utility of profiling somatic alterations in Indian cancer patients using a multi-gene next generation sequencing (NGS) test.
11. Targeted sequencing to confirm clinical diagnosis of Li-Fraumeni syndrome.
12. Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate
13. Revisiting the essentiality of glutamate racemase in Mycobacterium tuberculosis
14. Roles of the two type II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitro
15. N-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead Compounds
16. Diarylthiazole: An Antimycobacterial Scaffold Potentially Targeting PrrB-PrrA Two-Component System
17. Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship andIn VivoEfficacy in a Mouse Model of Tuberculosis
18. Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial Agents
19. 4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity
20. Novel N-Linked Aminopiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy against Mycobacterium tuberculosis
21. Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis
22. Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
23. Evaluation of CoA biosynthesis proteins of Mycobacterium tuberculosis as potential drug targets
24. Alanine racemase mutants of Mycobacterium tuberculosis require d-alanine for growth and are defective for survival in macrophages and mice
25. N-Aryl-2-aminobenzimidazoles:Novel, Efficacious, Antimalarial Lead Compounds.
26. Diarylthiazole: An AntimycobacterialScaffold PotentiallyTargeting PrrB-PrrA Two-Component System.
27. Aminoazabenzimidazoles, aNovel Class of Orally ActiveAntimalarial Agents.
28. Novel N-Linked Aminopiperidine-BasedGyraseInhibitors with Improved hERG and in Vivo Efficacy against Mycobacterium tuberculosis.
29. Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In VivoEfficacy in a Mouse Model of Tuberculosis
30. Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-beta-D-ribose 2 '-oxidase
31. Comprehensive And Sensitive Detection Of Somatic Mutations For Monitoring Minimal Residual Disease.
32. Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In VivoEfficacy in a Mouse Model of Tuberculosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.